FDA recall D-1258-2020

Akorn Inc · Class III · drug

Product

Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 10 Ampules per carton, (2 mL each), Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-030-02

Reason for recall

Failed impurities/degradation specification: Out-of-Specification result for total impurity at 4.1% (Limit: NMT 3.0%) during retained sample testing.

Distribution

Distributed Nationwide in the USA

Key facts

Status
Terminated
Initiation date
2020-03-25
Report date
2020-04-08
Termination date
2022-07-28
Voluntary/Mandated
Voluntary: Firm initiated
Location
Lake Forest, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1258-2020